Berkshire Hathaway more than doubles buybacks in third quarter as earnings decline

Berkshire Hathaway repurchased $9.6 billion of its shares in Q3, more than double Q2’s $4.5 billion, bringing 2026 buybacks to about $14.4 billion. Operating earnings fell 5.8% year over year to $12.705 billion, while overall earnings declined 28% to $22.112 billion; insurance underwriting profit dropped 43% to $1.352 billion. Berkshire shares gained more than 12% over the past month as the S&P 500 fell 5.5%, and cash holdings rose to $377.435 billion before specified exclusions.

Analysis

The buyback is a conditional valuation signal, not a floor: repurchases create value only if Berkshire is buying below intrinsic value, and the article provides no price, valuation, or authorization detail to test that. The larger strategic signal is that management is returning capital while keeping substantial liquidity optionality; however, the adjusted cash measure fell, so the headline cash balance overstates the quarter-on-quarter increase in readily available capital.

Near term, the relative-performance trade is vulnerable to reversal. Berkshire has become a beneficiary of a tech-led risk-off rotation, but its large public-equity holdings—including Apple and Alphabet—mean it is not a clean low-beta substitute for cash. If technology stabilizes, this look-through exposure could blunt the defensive premium while investors reassess weaker insurance results. The underwriting decline warrants monitoring, not extrapolation: catastrophe losses, reserve development, and pricing/retention data are needed to distinguish a temporary setback from deterioration. Lower investment income also needs decomposition before attributing it to rates or portfolio changes.

Over 1–3 months, the key catalysts are insurance disclosures and the next capital-allocation update. Over 6–18 months, the thesis depends on disciplined repurchases and deploying liquidity at attractive returns. Contrarian risk: investors may be treating buybacks as proof of undervaluation and the cash balance as wholly deployable, neither of which is established. A sustained deterioration in underwriting or evidence that repurchases continued despite weak valuation support would undermine the quality of the signal.

Key Decisions for Investors

• Avoid chasing the recent relative rally. Consider a tactical long BRK.A versus SPY only on a pullback or if the relative-strength premium narrows while insurance results stabilize; the trade is a defensive rotation expression, not a technology-hedge substitute.
• Keep the buyback as a modest support to the downside case, not a standalone buy signal. Verify repurchase prices/pace and management’s stated valuation framework before increasing exposure; absent that information, do not infer intrinsic value from buyback size.
• Monitor the next insurance disclosures for catastrophe losses, reserve development, underwriting margins, and renewal pricing. Persistent weakness beyond a quarter, or management commentary indicating weaker pricing/retention, would falsify the stabilization thesis and argue against the pair trade.
• Reduce or exit a relative long if BRK.A gives back its recent outperformance as technology leadership broadens, or if operating earnings weaken across insurance and the previously growing railroad, energy, and manufacturing businesses. The immediate risk is rotation reversal; the medium-term risk is a more durable insurance earnings reset.